Events4th International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session A. ECMC-4 of the event 4th International Electronic Conference on Medicinal Chemistry
Published date
16 Nov, 2018
Citation
Amani Direm, Mohammed S. M. Abdelbaky, Koray Sayın, Andrea Cornia, Olufunso Abosede, Santiago García-Granda, Biological activity of two new imidazole-based Cu(II) frameworks resulting from a one-pot reaction, in Proceedings of 4th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2018, MDPI: Basel, Switzerland, doi: 10.3390/ecmc-4-05859
Share
Email
Facebook
Twitter
LinkedIn

Biological activity of two new imidazole-based Cu(II) frameworks resulting from a one-pot reaction

Mohammed S. M. Abdelbaky 2
Koray Sayın 3
Andrea Cornia 4
Olufunso Abosede 5
1. Laboratoire des Structures, Propriétés et Interactions Interatomiques LASPI2A, Département des Sciences de la Matière, Faculté des Sciences et de la Technologie, Université ‘’Abbes Laghrour’’, Khenchela 40.000, Algeria
2. Departamento de Química Física y Analítica, Universidad de Oviedo – CINN, 33006 Oviedo, Spain
3. Department of Chemistry, Faculty of Science, Cumhuriyet University 58140 Sivas, Turkey
4. Dipartimento di Scienze Chimiche e Geologiche, Università di Modena e Reggio Emilia & INSTM, via G. Campi 103, 41125 Modena, Italy
5. Department of Chemistry, Federal University Otuoke, P.M.B 126, Yenagoa, Bayelsa State, Nigeria
Abstract

Imidazole occurs in most proteins as part of the side chain of histidine and constitutes a binding site for various transition metal ions in a large number of metalloproteins [1]. Consequently, the bonding between imidazole and transition metal ions is widely known [2] and of considerable interest especially in biological systems [3,4]. Consequently, copper(II)–imidazole systems with different ratios of imidazole to copper have been prepared and investigated by several researchers [5]. Moreover, being studied as models for copper proteins that contain both functionalities in the side chain [6], some mononuclear copper(II)–imidazole complexes with carboxylate ligands have been found to display a variety of pharmacological effects, including antitumor [7], superoxide dismutase and catecholase activities [8]. In order to contribute to the study of these systems, we have synthesized two new penta-coordinated copper(II) complexes with mixed-ligands, namely: imidazole and citric acid. The resulting compounds have shown remarkable antimicrobial and antifungal inhibition activities, which have been predicted by exploring the computational chemical reactivity of the two complexes [9].

References :

[1] J. Reedijk & E. Bouwman, Bioinorganic Catalysis, Marcel Dekker Inc., New York & Basel, 1999.

[2] K. D. Karlin & Z. Tyeklar, Bioinorganic Chemistry of Copper, Chapman & Hall, New York, 1993.

[3] E. Colacio, M. Ghazi, R. Kivekäs, M. Klinga, F. Lloret & J. M. Moreno, Inorg. Chem, 2000, 39(13), 2770–2776.

[4] M. T. Caudle, J. W. Kampf, M. L. Kirk, P. G. Rasmussen & V. L. Pecoraro, J. Am. Chem. Soc, 1997, 119(39), 9297–9298.

[5] (a) S. M. Morehouse, A. Polychronopoulou & G. J. B. Williams, Inorg. Chem, 1980, 19(12), 3558–3561. (b) G. Fransson & B. K. S. Lundberg, Acta Chem. Scand. A, 1974, 28(5), 578–588. (c) D. L. McFadden, A. T. McPhail, C. D. Garner & F. E. Mabbs, J. Chem. Soc., Dalton Trans, 1976, 47–52.

[6] H. Beinert, Coord. Chem. Rev, 1980, 33, 55.

[7] J. R. J. Sorrenson, Prog. Med. Chem, 1989, 26, 437. (and references therein).

[8] A. L. Abuhijleh & C. Woods, Inorg. Chim. Acta, 1993, 209, 187.

[9] Direm, A. Abdelbaky, M. S. M. Sayın, K. Cornia, A. Abosede, O. & García-Granda, S. (2018). Inorg. Chim. Acta. 478. 59–70.

Keywords
Imidazole-based complexes
Cu(II) frameworks
one-pot synthesis
crystal structure
ab-initio calculations
biological properties.
Poster
Direm-Revised Presentation.pdf
Pleiotropic focused anticancer approach by dihydropyridines, dihydropyrimidines and heteroaromatic compounds
Design potent peptide antibiotics against the ESKAPE pathogens based on human antimicrobial peptide LL-37